GBIO
Price
$1.83
Change
-$0.22 (-10.73%)
Updated
Nov 13 closing price
98 days until earnings call
LCTX
Price
$0.91
Change
-$0.04 (-4.21%)
Updated
Nov 13 closing price
Earnings call today
Ad is loading...

GBIO vs LCTX

Header iconGBIO vs LCTX Comparison
Open Charts GBIO vs LCTXBanner chart's image
Generation Bio
Price$1.83
Change-$0.22 (-10.73%)
Volume$249.17K
CapitalizationN/A
Lineage Cell Therapeutics
Price$0.91
Change-$0.04 (-4.21%)
Volume$432.08K
CapitalizationN/A
GBIO vs LCTX Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GBIO vs. LCTX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Buy and LCTX is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (GBIO: $1.83 vs. LCTX: $0.91)
Brand notoriety: GBIO and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 206% vs. LCTX: 100%
Market capitalization -- GBIO: $122.23M vs. LCTX: $172.41M
GBIO [@Biotechnology] is valued at $122.23M. LCTX’s [@Biotechnology] market capitalization is $172.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while LCTX’s TA Score has 6 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 4 bearish.
  • LCTX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than GBIO.

Price Growth

GBIO (@Biotechnology) experienced а -23.75% price change this week, while LCTX (@Biotechnology) price change was -1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

GBIO is expected to report earnings on Feb 20, 2025.

LCTX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($172M) has a higher market cap than GBIO($122M). GBIO YTD gains are higher at: 10.909 vs. LCTX (-16.239). LCTX has higher annual earnings (EBITDA): -24.93M vs. GBIO (-107.1M). GBIO has more cash in the bank: 217M vs. LCTX (38.5M). LCTX has less debt than GBIO: LCTX (2.95M) vs GBIO (94M). GBIO has higher revenues than LCTX: GBIO (13.2M) vs LCTX (6.19M).
GBIOLCTXGBIO / LCTX
Capitalization122M172M71%
EBITDA-107.1M-24.93M430%
Gain YTD10.909-16.239-67%
P/E RatioN/AN/A-
Revenue13.2M6.19M213%
Total Cash217M38.5M564%
Total Debt94M2.95M3,185%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOLCTX
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 14 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNTGY12.140.35
+2.97%
Brenntag SE
NLLSF0.320.01
+2.73%
Nel ASA
MPNGY44.09-0.05
-0.11%
MEITUAN
FANUY13.03-0.34
-2.54%
Fanuc Corporation
SYHBF0.28-0.01
-4.63%
Skyharbour Resources Ltd.

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ABOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-10.73%
ABOS - GBIO
49%
Loosely correlated
-5.42%
ATNM - GBIO
46%
Loosely correlated
-5.00%
EDIT - GBIO
45%
Loosely correlated
-3.58%
INZY - GBIO
45%
Loosely correlated
-5.59%
QSI - GBIO
45%
Loosely correlated
+2.05%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-3.77%
MDGL - LCTX
43%
Loosely correlated
-7.05%
GBIO - LCTX
38%
Loosely correlated
-10.73%
XNCR - LCTX
36%
Loosely correlated
-0.42%
KPTI - LCTX
35%
Loosely correlated
-3.52%
MGTX - LCTX
35%
Loosely correlated
+5.71%
More